The carcinoGENOMICS project: Critical selection of model compounds for the development of omics-based in vitro carcinogenicity screening assays

Mathieu Vinken, Yordanova Doktorova Tatyana, Heidrun Ellinger-Ziegelbauer, Hans-Jürgen Ahr, Edward Lock, Paul Carmichael, Erwin Roggen, Joost Van Delft, Jos Kleinjans, José Castell, Roque Bort, Teresa Donato, Michael Ryan, Raffaella Corvi, Hector Keun, Timothy Ebbels, Toby Athersuch, Susanna-Assunta Sansone, Philippe Rocca-Serra, Rob StierumPaul Jennings, Walter Pfaller, Hans Gmuender, Tamara Vanhaecke, Vera Rogiers

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Recent changes in the European legislation of chemical-related substances have forced the scientific community to speed up the search for alternative methods that could partly or fully replace animal experimentation. The Sixth Framework Program project carcinoGENOMICS was specifically raised to develop omics-based in vitro screens for testing the carcinogenic potential of chemical compounds in a pan-European context. This paper provides an in-depth analysis of the complexity of choosing suitable reference compounds used for creating and fine-tuning the in vitro carcinogenicity assays. First, a number of solid criteria for the selection of the model compounds are defined. Secondly, the strategy followed, including resources consulted, is described and the selected compounds are briefly illustrated. Finally, limitations and problems encountered during the selection procedure are discussed. Since selecting an appropriate set of chemicals is a frequent impediment in the early stages of similar research projects, the information provided in this paper might be extremely valuable.
Original languageEnglish
Pages (from-to)202-210
Number of pages8
JournalMutation Research - Reviews in Mutation Research
Volume659
Publication statusPublished - 26 Apr 2008

Keywords

  • carcinoGENOMICS
  • FP6 project
  • REACH
  • Chemical carcinogenesis
  • Genomics
  • Metabonomics
  • Metabolomics
  • Model compounds
  • Selection criteria
  • Genotoxic carcinogen
  • Non-genotoxic carcinogen

Fingerprint

Dive into the research topics of 'The carcinoGENOMICS project: Critical selection of model compounds for the development of omics-based in vitro carcinogenicity screening assays'. Together they form a unique fingerprint.

Cite this